Ryan Zimmerman
Stock Analyst at BTIG
(4.23)
# 444
Out of 5,090 analysts
220
Total ratings
58.29%
Success rate
11.92%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Upgrades: Buy | $100 | $85.43 | +17.05% | 2 | Dec 2, 2025 | |
| ALC Alcon | Reiterates: Buy | $91 | $80.73 | +12.72% | 13 | Nov 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.23 | +387.80% | 6 | Nov 21, 2025 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $87 | $85.46 | +1.80% | 4 | Nov 21, 2025 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $7 → $9 | $4.74 | +89.87% | 8 | Nov 20, 2025 | |
| RCEL AVITA Medical | Upgrades: Neutral | n/a | $3.50 | - | 4 | Nov 20, 2025 | |
| SYK Stryker | Reiterates: Buy | $410 | $364.02 | +12.63% | 18 | Nov 14, 2025 | |
| MDAI Spectral AI | Maintains: Buy | $3.5 → $3 | $1.65 | +81.82% | 2 | Nov 12, 2025 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $2 → $1.5 | $0.62 | +143.51% | 3 | Nov 11, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Neutral | n/a | $2.74 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $24 | $13.26 | +81.00% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $112 | $94.28 | +18.80% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $27.91 | +0.32% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $116 | $108.51 | +6.90% | 14 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $18.42 | +24.86% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $300.66 | +6.43% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $529 → $589 | $575.34 | +2.37% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $74.97 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $178.37 | +9.32% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.23 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $35.86 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $15.20 | +51.32% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $125.08 | +18.32% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.63 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $91.10 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $13.23 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $25.38 | +108.83% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.98 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.90 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $141.68 | +41.16% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $304.49 | +14.95% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $101.36 | +26.28% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.20 | +33.93% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.68 | +137.56% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.82 | +989.21% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.32 | - | 3 | Apr 2, 2020 |
Solventum
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $85.43
Upside: +17.05%
Alcon
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $80.73
Upside: +12.72%
Humacyte
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $1.23
Upside: +387.80%
GE HealthCare Technologies
Nov 21, 2025
Reiterates: Buy
Price Target: $87
Current: $85.46
Upside: +1.80%
Organogenesis Holdings
Nov 20, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $4.74
Upside: +89.87%
AVITA Medical
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.50
Upside: -
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $410
Current: $364.02
Upside: +12.63%
Spectral AI
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.65
Upside: +81.82%
Xtant Medical Holdings
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.62
Upside: +143.51%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.74
Upside: -
Nov 7, 2025
Maintains: Buy
Price Target: $21 → $24
Current: $13.26
Upside: +81.00%
Nov 5, 2025
Maintains: Buy
Price Target: $122 → $112
Current: $94.28
Upside: +18.80%
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $27.91
Upside: +0.32%
Oct 30, 2025
Maintains: Buy
Price Target: $104 → $116
Current: $108.51
Upside: +6.90%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $18.42
Upside: +24.86%
Oct 27, 2025
Reiterates: Buy
Price Target: $320
Current: $300.66
Upside: +6.43%
Oct 22, 2025
Maintains: Buy
Price Target: $529 → $589
Current: $575.34
Upside: +2.37%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $74.97
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $178.37
Upside: +9.32%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $36.23
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $35.86
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $15.20
Upside: +51.32%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $125.08
Upside: +18.32%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $12.63
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $91.10
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $13.23
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $25.38
Upside: +108.83%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.98
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.90
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $141.68
Upside: +41.16%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $304.49
Upside: +14.95%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $101.36
Upside: +26.28%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.20
Upside: +33.93%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.68
Upside: +137.56%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.82
Upside: +989.21%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $33.32
Upside: -